CDK1 and hepatocellular carcinoma: The nuclear localization of YES1 with CDK1 has been observed during the initial phases of hepatocarcinogenesis and in well-differentiated HCC, implying that the presence of YES1 within the nucleus could serve as a valuable indicator for detecting early-stage HCC [86].